期刊文献+

三阴性乳腺癌辅助化疗的研究进展

原文传递
导出
摘要 总结近几年关于三阴性乳腺癌(T N B C)辅助化疗的研究进展。以"三阴性乳腺癌、化疗"等为关键词,检索相关文献,纳入标准:(1)三阴性乳腺癌的特点;(2)T N B C化疗方案。目前对早期T N B C患者辅助化疗方案之间的疗效比较是回顾性的,分析结果显示与环磷酰胺和阿霉素联合时,紫杉醇比5-氟尿嘧啶更有效;经典的C M F方案(环磷酰胺,甲氨蝶呤和5-氟尿嘧啶)对T N B C有效;卡培他滨能增加紫杉醇联合蒽环类方案的疗效,但需进一步观察。对早期T N B C辅助治疗尚缺乏来自于前瞻性研究的数据,几个方案如含紫杉醇和蒽环类方案或经典的C M F方案可作为选择。
作者 马侠
出处 《中国城乡企业卫生》 2014年第3期11-12,共2页 Chinese Journal of Urban and Rural Enterprise Hygiene
  • 相关文献

参考文献16

  • 1Yamamoto Y, lwase H. Clinicopathological features and treatment strategy for triple-negative breast cancer[J].Int J Clin Oncol, 2010,15 (4):341-351.
  • 2Prat A, Perou CM. Deeonstructing the molecular portraits of breast cancer[J]. Mol Oncol, 2011,5 ( 1 ) : 5-23.
  • 3Prat A, Parker JS, Karginova O, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer [J].Breast Cancer Res, 2010,12(5 ) : R68.
  • 4Colleoni M, Cole BF, Viale G, et al. Classical cyclophosphamide, methotrexate,andfluorouracil chemotherapy is more effective in triple-negative,node-negative breast cancer:results from two ran- domized trials of adjuvant chemoendocrine therapy for node-negative breast cancer[J]. J Clin Oncol, 2010,28 : 2966-2973.
  • 5Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer[J]. J Clin Oncol,2008,26(8) : 1275-1281.
  • 6Martin M, Segui MA, Anton A, et al. Adjuvant docetaxel for high- risk,node-negative breast cancer [J]. N Engl J Med,2010,363(23): 2200-2210.
  • 7Hugh J, Hanson J, Cheang MC, et al. Breast cancer subtypes and re- sponse to docetaxel in node-positive breast cancer:use of an im- munohistochemical definition in the BCIRG 001 trial [J]. J Clin On- col,2009,27(8) : 1168-1176.
  • 8Hayes DF, Thor AD, Dressier LG, et al. HER2 and response to pacli- taxel in node-positive breast cancer [J]. N Engl J Med,2007,357 ( 15 ) : 1496-1506.
  • 9廖宁,张国淳,李学瑞,姚濛,王坤,祖健.新辅助紫杉醇联合曲妥珠单抗在表皮生长因子受体2阳性可手术乳腺癌患者中的疗效及安全性评价[J].中华肿瘤杂志,2010,32(7):544-547. 被引量:12
  • 10Muss HB, Berry DA, Cirrincione CT, et al. Adjuvant chemotherapy in older women with early-stage breast cancer [J].N Engl J Med, 2009,360( 20 ) : 2055-2065.

二级参考文献17

  • 1Demonty G,Bernard-Marty C,Puglisi F,et al.Progress and new standards of care in the management of HER-2 positive breast cancer.Eur J Cancer,2007,43:497-509.
  • 2Piccart-Gebhart MJ,Procter M,Leyland-Jones B,et al.Trastuzumab after adjuvant chemotherapy in HEK2-positive breast cancer.N Engl J Med,2005,353:1659-1672.
  • 3Romond EH,Perez EA,Bryant J,et al.Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.N Engl J Med,2005,353:1673-1684.
  • 4Vogel CL,Cobleigh MA,Tripathy D,et al.Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.J Clin Oncol,2002,20:719-726.
  • 5Slamon DJ,Leyland-Jones B,Shak S,et al.Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.N Engl J Med,2001,344:783-792.
  • 6Mauri D,Pavlidis N,Ioannidis JP.Neoadjuvant versus adjuvant systemic treatment in breast cancer; a meta-analysis.J Natl Cancer Inst,2005,97:188-194.
  • 7van der Hage JA,van de Velde CJ,Julien JP,et al.Preoperative chemotherapy in primary operable breast cancer:results from the European Organization for Research and Treatment of Cancer trial 10902.J Clin Oncol,2001,19:42244237.
  • 8Wolmark N,Wang J,Mamounas E,et al.Preoperative chemotherapy in patients with operable breast cancer; nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.J Natl Cancer Inst Monogr,2001,30:96-102.
  • 9Lazaridis G,Pentheroudakis G,Pavlidis N.Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer; accumulating evidence of efficacy,synergy and safety.Crit Rev Oncol Hematol,2008,66:3141.
  • 10Chevallier B,Roche H,Olivier JP,et al.Inflammatory breast cancer.Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate.Am J Clin Oncol,1993,16:223-228.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部